Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Humana Inc (HUM) vs Vital Farms Inc (VITL) Price & Performance

Humana IncTrade
Vital Farms IncTrade

Price performance (Past 24H)

Key statistics

Humana Inc vs Vital Farms Inc — how do they compare? Humana Inc trades at $449.75 (market cap $46.49B), while Vital Farms Inc trades at $9.44 (market cap $405.27M). The key difference: Humana Inc is far larger — about 114.7× Vital Farms Inc's market cap, and Humana Inc pays a 0.91% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Vital Farms Inc for 14 Days on average.

HUMVITL
Market Cap
$46.49B$405.27M
Volume
2,567,7041,810,837
Sector
HealthConsumer Staples
52-Week High
$409.85$43.68
52-Week Low
$163.67$8.28
Typical Hold Time
53 Days14 Days
Enterprise Value
$53.84B$492.28M
Dividend Yield
0.91%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Humana Inc

Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.

The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.

Vital Farms Inc

Vital Farms (VITL) trades at $9.24, down 1.7% on the day, reflecting ongoing pressure from weak earnings and industry headwinds. The stock shows a bearish technical trend with key support at $9.00, while fundamentals reveal a sharp decline in profitability with a net margin of just 0.02% in 2026. Recent news highlights strategic review discussions and institutional acquisitions, yet negative cash flow and pricing challenges in the egg market weigh on investor confidence.

The outlook remains cautious with significant execution risks amid industry oversupply, though analyst consensus suggests upside potential to a $13.11 price target. Investment opportunity hinges on a successful strategic review and margin recovery, but risks include sustained cash burn and competitive pressures that could limit near-term gains.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HUM

No sentiment data available yet.

VITL
0% Buy100% Sell
Avg holding period · 14 Days

Top news

Latest headlines on both assets

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM →

About Vital Farms Inc

Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.

Read more on VITL →